According to a new market report published by Lucintel, the future of the allergy diagnostic market looks promising with opportunities in the diagnostics laboratories, hospital-based laboratories, academic and research institutes. The allergy diagnostics market is expected to grow with a CAGR of 11% from 2019 to 2024. The major drivers for this market are rising environmental pollution levels, growing incidences of allergic reactions, increasing healthcare expenditure, and increasing access for allergy diagnosis medical insurance.
In this market, assay kits, instruments, and services are the major product type. Assay kits is the largest product segment of the allergy diagnostic market.
Within the allergy diagnostics market, in vivo tests and in vitro tests are the major test types. In vivo tests is the largest segment of the allergy diagnostic market.
North America will remain the largest region over the forecast period due to high awareness about allergy diagnostic test among individuals, better regulatory guidelines which mandate allergic testing in all cases of intensive and emergency care, and better healthcare infrastructure to deal with patient’s allergic situations.
Thermo Fisher Scientific, Siemens, Danaher, Omega Diagnostics Group, Hitachi Chemical, Biomérieux, Stallergenes Greer, Hob Biotech Group Suzhou, Hycor Biomedical, Lincoln Diagnostics, and R-Biopharm are among the major manufacturers of allergy diagnostics.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the allergy diagnostics market by product and service, test type, allergen, end user, and region. Lucintel has prepared a comprehensive research report titled " Allergy Diagnostics Market 2019-2024: Trends, Forecast, and Opportunity Analysis". The Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the allergy diagnostics market by product and service, test type, allergen, end user, and region as follows:
By Product and Service [$M shipment analysis for 2013 – 2024]:
• Assay Kits
• Instruments
• Services
By Test Type [$M shipment analysis for 2013 – 2024]:
• In Vivo Tests
• In Vitro Tests
By Allergen [$M shipment analysis for 2013 – 2024]:
• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Other Allergens
By End User [$M shipment analysis for 2013 – 2024]:
• Diagnostics Laboratories
• Hospital-based Laboratories
• Academic and Research Institutes
• Other End Users
By Region [$M shipment analysis for 2013 – 2024]:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
• Asia-Pacific
o China
o India
o Japan
• ROW
o Brazil
A report of more than 150 pages will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report addresses the following key questions:
Q.1 What are some of the most promising potential, high-growth opportunities for the allergy diagnostics market by product & service (assay kits, instruments, and services), test type (in vivo tests and in vitro tests), allergen (inhaled allergens, food allergens, drug allergens, and other allergens), end user (diagnostics laboratories, hospital-based laboratories, academic and research institutes, and other end users), and region (North America, Europe, Asia-Pacific, and ROW)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which regions will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the allergy diagnostics market?
Q.5 What are the business risks and threats to the allergy diagnostics market?
Q.6 What are emerging trends in this allergy diagnostics market and the reasons behind them?
Q.7 What are some changing demands of customers in the allergy diagnostics market?
Q.8 What are the new developments in the allergy diagnostics market? Which companies are leading these developments?
Q.9 Who are the major players in this allergy diagnostics market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this allergy diagnostics area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M & A activities have taken place in the last 5 years in allergy diagnostics market?